The results showed that the serum level of IFN-γ was significantly lower in PR patients (6.33±11.02 pg/ml) than in healthy controls (29.23±35.45 pg/ml) (p＜0.05; Fig. 1 ), whereas the serum levels of IL-2, IL-4, and IL-10 were not significantly different between the two groups. Additionally, no statistical difference was observed in the serum levels of IL-2, IL-4, IL-10, and IFN-γ between the male and female patients and between patients who had PR for less than 3 weeks and those who had PR for 3 or more weeks (p＞0.05).
To date, only a few studies that discuss the association of the Th1/Th2 immune response with PR have been published. A study showed that tumor necrosis factor-alpha inhibitors such as adalimumab could induce PR by downregulating the Th1 immune response 3 . In our study, a significant decrease in the serum level of IFN-γ was observed in patients with PR than in the healthy controls, but no statistically significant differences were observed in the levels of IL-2, IL-4, and IL-10 between the two groups. Serum IFN-γ is produced by activated CD4 + T cells and activated natural killer cells and might be the most sensitive marker of the CD4 + T cells response to HHV-6 infection 4 . Gangemi et al. 5 found that the serum level of IL-22 was significantly higher in patients with an early stage of PR than in healthy controls and that IL-22 could limit the transmission of HHV-7 infection in PR by enhancing the production of proinflammatory and antimicrobial molecules. Moreover, diverse, fractalkine-mediated intracellular signaling pathways were involved in the pathogenesis of PR via the fractalkine receptor CX3CR1 in natural killer cells, monocytes, CD8 + T cells, and CD4 + T cells 6 .
The process by which CD4 + T cells produce IFN-γ and IL-22 is regulated by different signaling molecules. Recently, Qiu et al. 7 first described the reciprocal relationship between IFN-γ and IL-22 production. IL-22 production is markedly enhanced when IFN-γ is absent. The detectable IL-22 mediates the up-regulation of CD27 expression in IFN-γ + CD4 + T cells and thus affects their phenotype. Usually, acute viral infections induce an increase in the serum level of IFN-γ . Moreover, many studies have suggested the involvement of HHV infection in the pathogenesis of PR. Our findings seem to yield a contradictory result. We postulate that the decrease in the serum level of IFN-γ is most likely linked to the decreased number or impaired function of peripheral CD4 + T cells in the PR patients involved in this study.
In conclusion, we speculate that our study is the first to demonstrate a depletion in the serum level of IFN-γ and that a weakened Th1 response may contribute to the pathogenesis of PR. Further studies are needed to elucidate the alteration of CD4 + T cells in PR and whether the decreased serum level of IFN-γ and the elevated serum level of IL-22 have a synergetic influence on the development of this acute dermatosis.
